Syngene International Limited Share Price and Company Fundamentals

-8.650 (-1.445%)
52 week
510.05 - 683.0

Last traded: Today at 9:59 AM

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also offers exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services. In addition, the company provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical, central lab, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. Further, it offers other drug modalities, which include peptides, oligonucleotide synthesis, antibody drug conjugate, PROTACs, and CAR T-cell therapy services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, specialty chemical, and other companies. It has partnerships and collaborations with Bristol-Myers Squibb Co.; Baxter Inc.; and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Industry / Sector Biotechnology / Healthcare
Full time employees 5975
Mailing address Biocon SEZ, Biocon Park, Plot No. 2 & 3 Bommasandra Industrial Area, IV Phase Jigani Link Road, Bommasandra Bengaluru 560099 India
Phone / Fax 91 80 2808 2808 / 91 80 4014 3150


Dividend yield


Dividend amount


Payout ratio


Syngene International Limited paid ₹0.00 dividend and the ex-dividend date was 30 June 2022.The dividend payout ratio is 4.69%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.SYNGENE dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

SYNGENE's forward dividend amount is ₹0.5 and the forward dividend yield is 0.08%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Dec 2022, following are the company executives and directors listed on Syngene International Limited.

Name Title Age Total Pay
Mr. Jonathan Brittan Hunt MD, CEO & Exec. Director 52 76.31M
Mr. Sibaji Biswas Chief Financial Officer
Dr. Mahesh Bhalgat Ph.D. Chief Operating Officer
Krishnan G Head of Investor Relations
Ms. Priyadarshini Mahapatra C.S. Company Sec. & Compliance Officer
Mr. Sandeep Nair Head of Corp. Communications
Mr. Sanjeev Sukumaran Chief HR Officer
Dr. Dhananjay Patankar Head of Pharmaceutical & Biopharmaceutical Devel.
Mr. Purushottam Shashikant Singnurkar Head of Formulations Devel.
Mr. Ajit Manocha Head of IT

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Syngene International Limited is and its enterprise value is .

The SYNGENE's stocks Beta value is 0.56 making it 44% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Syngene International Limited (NSE:SYNGENE) Frequently Asked Questions

1. What is Syngene International Limited's Stock Symbol?

Syngene International Limited trades on NSE under the ticker symbol "SYNGENE".

2. What is Syngene International Limited's stock price today?

One share of SYNGENE stock can currently be purchased for approximately ₹590.05.

3. How can I contact Syngene International Limited?

Syngene International Limited's mailing address is Biocon SEZ, Biocon Park, Plot No. 2 & 3 Bommasandra Industrial Area, IV Phase Jigani Link Road, Bommasandra Bengaluru 560099 India. The company can be reached via phone at 91 80 2808 2808.

4. What is Syngene International Limited's official website?

The official website of Syngene International Limited is